Results 31 to 40 of about 47,543 (305)

High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy [PDF]

, 2012
Purpose: To investigate the prognostic value of survivin expression in pretreatment specimens from patients with anal cancer treated with concurrent 5-FU and mitomycin C-based chemoradiation (CRT).
Distel, Luitpold Valentin Rudolf, Falk, Stefan, Fraunholz, Ingeborg, Kohler, Daniela, Rave-Fränk, Margret, Rödel, Claus, Rödel, Franz   +6 more
core   +2 more sources

Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancer [PDF]

Radiation Oncology Journal, 2014
Survival outcome of locally advanced pancreatic cancer has been poor and little is known about prognostic factors of the disease, especially in locally advanced cases treated with concurrent chemoradiation. This study was to analyze overall survival and prognostic factors of patients treated with concurrent chemoradiotherapy (CCRT) in locally advanced ...
Kwak, Yoo-Kang, Lee, Jong Hoon, Lee, Myung-Ah, Chun, Hoo-Geun, Kim, Dong-Goo, You, Young Kyoung, Hong, Tae-Ho, Jang, Hong Seok   +7 more
openaire   +2 more sources

Concurrent Chemoradiotherapy with Original Chemotherapy Regimens may not be Suitable for Patients Who Failed to Respond to Induction Chemotherapy
in Limited-stage Small Cell Lung Cancer

Chinese Journal of Lung Cancer, 2016
Background and objective The group of small cell lung cancer (SCLC) are usually highly sensitive to chemotherapy, and less than 15% of them are resistant to drugs.
Daquan WANG, Liming XU, Lujun ZHAO, Wencheng ZHANG, Qingsong PANG, Ningbo LIU, Xi CHEN, Xiuli CHEN, Zhiyong YUAN, Ping WANG   +9 more
doaj   +1 more source

Prognosis of Stage ⅠB-ⅡA Cervical Squamous Cell Carcinoma Patients with Intermediate Risk Factors Treated with Adjuvant Chemotherapy Versus Concurrent Chemoradiotherapy: A Prospective Randomized Controlled Trial

Zhongliu Fangzhi Yanjiu, 2021
Objective To compare the prognosis of stage ⅠB-ⅡA cervical squamous cell carcinoma patients with intermediate risk factrs between adjuvant chemotherapy and concurrent chemoradiotherapy, and to explore the safety and effectiveness of adjuvant chemotherapy
PAN Zhongmian, CHEN Qi, LI Li
doaj   +1 more source

Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer [PDF]

, 2013
Background: Preoperative radiochemotherapy (RCT) with 5-FU or capecitabine is the standard of care for patients with locally advanced rectal cancer (LARC). Preoperative RCT achieves pathological complete response rates (pCR) of 10-15%.
Arnold, Dirk, Dellas, Kathrin, Dunst, Jürgen, Engel, Erik, Höhler, Thomas, Reese, Thomas, Richter, Michael, Rödel, Claus, Wagner, Wolfgang, Würschmidt, Florian   +9 more
core   +1 more source

Prognostic implication of simultaneous anemia and lymphopenia during concurrent chemoradiotherapy in cervical squamous cell carcinoma

Tumor Biology, 2017
Radioresistance often leads to poor survival in concurrent chemoradiotherapy–treated cervical squamous cell carcinoma, and reliable biomarkers can improve prognosis.
Oyeon Cho, Mison Chun, Young-Taek Oh, O Kyu Noh, Suk-Joon Chang, Hee-Sug Ryu, Eun Ju Lee   +6 more
doaj   +1 more source

Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy

BMC Cancer, 2019
Background and objectives The survival rate of patients with advanced oesophageal cancer is very low and can vary significantly, even among patients with the same TNM stage. It is important to look for indicators that are economical and readily available
Ke-Jie Li, Xiao-Fang Xia, Meng Su, Hui Zhang, Wen-Hao Chen, Chang-Lin Zou   +5 more
doaj   +1 more source

Interventions for the treatment of oral cavity and oropharyngeal cancer:chemotherapy [PDF]

, 2010
<b>Background:</b> Oral cavity and oropharyngeal cancers are frequently described as part of a group of oral cancers or head and neck cancer. Treatment of oral cavity cancer is generally surgery followed by radiotherapy, whereas oropharyngeal
Abdel Wahab, Abele, Adelstein, Adelstein, Adelstein, Andreadis, Andres, Anonymous, Anonymous, Ansfield, Arcangeli, Aref, Attner, Bachaud, Bakowski, Bensadoun, Berger, Bernier, Bernier, Bezwoda, Biakhov, Biakhov, Bitter, Bitter, Blasio, Boidi, Bolla, Bonner, Bourhis, Bourhis, Bradley, Brigham, Brizel, Browman, Browman, Browman, Browman, Browman, Browman, Browman, Browman, Brunin, Brunin, Budach, Budach, Buentzel, Buentzel, Buntzel, Buntzel, Buntzel, Buntzel, Cachin, Calais, Calais, Calais, Calais, Calais, Calais, Caponigro, Caponigro, Cappelaere, Cappelaere, Carugati, Chassagne, Chauvergne, Chauvergne, Clavel, Clifford, Coates, Coninx, Coninx, Conway, Cooper, Corey, Corvo, Corvo, Corvo, Crispino, Cruz, Cummings, Dalley, Datta, Day, DeConti, Denis, Denis, Depondt, Dobrowsky, Dobrowsky, Domenge, Domenge, Domenge, Domenge, Ebeling, Eschwege, Eschwege, Ezra, Faggiano, Fakhry, Fanucchi, Fazekas, Fazekas, Fety, Fety, Fonseca, Forastiere, Fountzilas, Fountzilas, Fu, Fu, Fujii, Fujii, Funk, Furukawa, Gabriele, Gasparini, Gedouin, Gedouin, Gehanno, Gibson, Gladkov, Gollin, Gonzalez-Larriba, Grandi, Grau, Grau, Grau, Griem, Gupta, Gupta, Haas, Haas, Haas, Haddad, Haddadin, Haffty, Haffty, Haffty, Haffty, Haffty, Hafty, Handa, Harari, Hasegawa, Haselow, Henk, Heyden, Heyden, Heyden, Heyden, Heyden, Heyden, Hitt, Holoye, Holoye, Homma, Hong, Hughes, Huguenin, Hussey, Jacobs, Jain, Jaulerry, Jeremic, Jeremic, Jeremic, Jeremic, Jeremic, Jones, Jortay, Kaneda, Kapstad, Kapstad, Katori, Keegan, Knowlton, Kotani, Kramer, Krishnamurthi, Kumar, Laccourreye, Lam, Laramore, Lavertu, Le, Le, Lee, Lewin, Licitra, Lim, Lippman, Lo, Lopes, Luboinski, Macfarlane, Magno, Maipang, Mantovani, Marechal, Martin, Martin, Martin, Mazeron, McGurk, Mechl, Merlano, Merlano, Merlano, Merlano, Merlano, Merlano, Mohr, Monson, Morita, Morton, Morton, Nervi, Nissenbaum, O'Connor, Olasz, Olasz, Oliver, Oliver, Olmi, Olmi, Paccagnella, Paccagnella, Panis, Papac, Parkin, Parmar, Partridge, Parvinen, Patel, Pavitt, Pearlman, Pentenero, Petrovich, Petrovich, Phillips, Pignon, Pinnaro, Pinto, Platzer, Posner, Price, Prévost, Racadot, Rao, Rao, Rapoport, Rasch, Rasch, Rentschler, Richard, Richard, Richard, Richard, Rischin, Rischin, Rischin, Rodrigo, Ruo Redda, Ryerson, Salvajoli, Sanchiz, Sanguineti, Schildhauer, Schildhauer, Schroder, Schuller, Schuller, Schuller, Sealy, Segura, Semrau, Shah, Shanta, Shaw, Shetty, Siodlak, Smid, Smid, Soo, Specenier, Staar, Staar, Stefani, Stefani, Stell, Stell, Sturgis, Suwinski, Szabo, Szpirglas, Szpirglas, Szpirglas, Taylor, Taylor, Taylor, Tejedor, Tepmongkol, Tobias, Tobias, Tobias, Tobias, Toohill, Toohill, Tsukuda, Tsukuda, Valverde, Vecchia, Vega, Vermund, Veronesi, Volling, Volling, Volling, Weissberg, Weissberg, Weissberg, Weissberg, Weissberg, Weissler, Wendt, Wendt, WHO, Woods, Woods, Woods, Woolgar, Yoshino, Yoshino, Zakotnik, Zakotnik, Zakotnik, Zorat, Zorat   +337 more
core   +9 more sources

A prospective randomized trial comparing accelerated concurrent chemoradiotherapy with conventional concurrent chemoradiotherapy in locally advanced carcinoma cervix (IIA–IVA)

Journal of Cancer Research and Therapeutics, 2021
Introduction: Cervical cancer ranks fourth in women worldwide. The management requires a multidisciplinary approach. Concomitant chemoradiotherapy with cisplatin, followed by brachytherapy, is the standard approach. Accelerated radiotherapy (ART) can be used to decrease the treatment duration which can further lead to better ...
Poorva, Vias, Harpreet, Angural, Rajeev Kumar, Seam, Manoj Kumar, Gupta, Manish, Gupta, Vikas, Fotedar, Anup, Negi   +6 more
openaire   +2 more sources

Comparison of the clinical efficacy between single-agent and dual-agent concurrent chemoradiotherapy in the treatment of unresectable esophageal squamous cell carcinoma: a multicenter retrospective analysis

Radiation Oncology, 2018
Background Some Chinese patients with esophageal squamous cell carcinomaare often treated with single-agent concurrent chemoradiotherapy. However, no results have been reported from randomized controlled clinical trials comparing single-agent with double-
Jie Li, Youling Gong, Peng Diao, Qingmei Huang, Yixue Wen, Binwei Lin, Hongwei Cai, Honggang Tian, Bing He, Lanlan Ji, Ping Guo, Jidong Miao, Xiaobo Du   +12 more
doaj   +1 more source